Brief: Electrocore Inc says relative ischemic lesion growth decreased by 65.9% with NVNS vs SHAM treatment.

electroCore,.

09/02/2022 13:51

Feb 9 (Reuters) - 
    * DATA PRESENTED AT 2022 INTERNATIONAL STROKE CONGRESS
SUGGESTS
ROLE FOR NON-INVASIVE VAGUS NERVE STIMULATION (NVNS) FOR
TREATMENT OF ACUTE STROKE
    * ELECTROCORE, INC. - RELATIVE ISCHEMIC LESION GROWTH
DECREASED BY
65.9% WITH NVNS VERSUS. SHAM TREATMENT.

Source text for Eikon:  ID:nGNX1B2276 
Further company coverage:  ECOR.O